Kaja Zarakowska | Head of Medical Diagnosis Innovation
UCB

Kaja Zarakowska, Head of Medical Diagnosis Innovation, UCB

Kaja, a dedicated MPharm professional (PharmD/US) with a solid background in genomics and entrepreneurship, is passionate about advancing healthcare through innovative approaches. Specializing in genomic medicine, rare genetic disorders, and AI in healthcare, she focuses on early diagnosis of pre-symptomatic and early-symptomatic rare disease patients.

Committed to increasing diagnostic rates and reducing the burden of diseases, Kaja leverages a digital approach, genetic screening, newborn screening, consortia-based initiatives, and partnerships. Her collaborative spirit extends to working with key opinion leaders, medical experts, ventures, incubators, start-ups, and more.

With a growth-oriented and creative mindset, Kaja is a connector, original thinker, and results-driven professional. As an enthusiastic and collaborative leader, she navigates the intersection of healthcare and technology to make a meaningful impact.

Appearances:



Day 1 - Tuesday 28 October @ 15:00

Panel: Reimagining Diagnosis in the Era of Patient-Centered Healthcare

For many patients, the path to an accurate diagnosis is long, complex, and often life-altering. This panel will explore how timely and precise diagnosis can influence patient well-being, access to care, and long-term outcomes. By bringing together perspectives from clinicians, patient advocates, and healthcare experts, we will discuss opportunities to shorten diagnostic journeys, reduce uncertainty, and ensure that the process itself supports true patient centricity.

Session led by: UCB
last published: 30/Sep/25 16:15 GMT

back to speakers

Get involved at World Orphan Drug Congress Europe 2025

 

 

TO SPONSOR


Steph Scanlon

Steph.Scanlon@terrapinn.com

 

TO SPEAK


Abdu Kauroo
Abdu.Kauroo@terrapinn.com

 

MARKETING & PRESS


Jasper Cameron

Jasper.Cameron@terrapinn.com

 

Stay Up-to-Date

Join our mailing list to receive exclusive content and offers.

By submitting, you agree to receive email communications from Terrapinn, including upcoming promotions and discounted tickets and news.